Community Services Navigation to Advance Health Equity in Breast Cancer Screening

NCT ID: NCT06305312

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1450 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-30

Study Completion Date

2028-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectiveness of social needs referrals combined with a community services navigation intervention in the screening mammography setting to improving breast screening outcomes in underserved women.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Disparities in breast cancer outcomes are persistent. In the United States, breast cancer is the most common, and second most deadly, cancer in women, with an estimated 281,550 new invasive breast cancer diagnoses and 43,600 breast cancer deaths in 2021. Underserved women, those who do not have adequate access to medical care, are represented disproportionately in those deaths, having lower incidence rates but higher mortality rates. While U.S. breast cancer mortality rates have decreased approximately 2% per year since 1990, socially and economically disadvantaged women have experienced increasing breast cancer mortality over that time. Rural women are more likely to experience diagnostic delays and are up to 1.5 times more likely to be diagnosed with advanced stages of disease compared with urban women.

Leveraging existing social systems for community navigation to facilitate breast screening follow-up. Our research has demonstrated that linkages between social needs screening in clinical settings and United Way 211's community referral service is possible using existing, low cost software solutions that can be adapted to clinical workflows. Specifically, the SINCERE 10-item social needs screener was combined with community services navigation and tested in a randomized controlled trial. That trial showed efficacy of the efficacy of this low cost, widely available solution to address the needs of vulnerable and underserved patients; namely, 211 active outreach v. passive information to address reported social needs. However, that trial was conducted in an Emergency Department, and has not been tested in other clinical settings. Building off of (collective) decades of work in breast cancer screening, the multiple PIs have formed an interdisciplinary team that has piloted an adaptation of the SINCERE social services screener (dubbed "B-SINCERE") in mammography clinics. This study will test the real-world efficacy (NIH stage 3) of the B-SINCERE community navigation intervention on increasing breast cancer screening episode completion. If efficacious, this intervention will be scalable with statewide community service providers and existing health information technology. Thus, the promise to make a real impact on early detection and improve breast cancer outcomes for underserved women with abnormal mammograms is the overarching driver of this work

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

Standard referrals to community resources will be used for participants randomized to usual care.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

Standard referral to community resources.

Intervention

Community Services Navigation with 211 Information Specialists (ISs) will conduct outreach to participants within 48 hours of referral through telephone, text, or email, depending on patient preference. Two weeks after initial contact ISs follow up with patients to provide additional support and document use of the referred services in ServicePoint.

Group Type EXPERIMENTAL

Community Service Navigation

Intervention Type BEHAVIORAL

Patients randomized to the intervention will be directly referred to the United Way of Salt Lake's 211 community referral service for additional outreach.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Community Service Navigation

Patients randomized to the intervention will be directly referred to the United Way of Salt Lake's 211 community referral service for additional outreach.

Intervention Type BEHAVIORAL

Usual Care

Standard referral to community resources.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English and Spanish speakers
* Received an abnormal result of a screening mammogram
* Self-reports at least one social need on the B-SINCERE Screener

Exclusion Criteria

* Patients who are currently in treatment for breast cancer
* Patients with a normal screening result.
* Patients who do not exhibit at least 1 social need according to their SINCERE screening result.
* Patients who don't speak English or Spanish
* Cognitive limitations that impede informed consent
* Patients living outside of Utah
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

University of Utah

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elissa Ozanne, PhD

Role: PRINCIPAL_INVESTIGATOR

Huntsman Cancer Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences

Salt Lake City, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elissa Ozanne, PhD

Role: CONTACT

801-213-4130

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elissa Ozanne, PhD

Role: primary

801-213-4130

References

Explore related publications, articles, or registry entries linked to this study.

Cancer Stat Facts: Female Breast Cancer. 2022; https://seer.cancer.gov/statfacts/html/breast.html. Accessed Jul 11, 2022.

Reference Type BACKGROUND

Underserved group. Toolkit for Patient-Focused Therapy Development https://toolkit.ncats.nih.gov/glossary/underserved-group/. Accessed September 30, 2022.

Reference Type BACKGROUND

American Cancer Society. Cancer Facts & Figures for Hispanics/Latinos 2018-2020. Atlanta2018.

Reference Type BACKGROUND

Centers for Disease Control and Prevention National Center for Health Statistics. Death Rates for Selected Cancers by Race and Ethnicity, US, 2010-2014. 2016; https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/death-rates-for-selected-cancers-by-race-and-ethnicity-us-2010-2014.pdf. Accessed Oct 11, 2021.

Reference Type BACKGROUND

Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L. Rural-Urban Differences in Cancer Incidence and Trends in the United States. Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1265-1274. doi: 10.1158/1055-9965.EPI-17-0430. Epub 2017 Jul 27.

Reference Type BACKGROUND
PMID: 28751476 (View on PubMed)

Death Rates for Selected Cancers by Race and Ethnicity, US, 2010-2014. 2016; https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2017/death-rates-for-selected-cancers-by-race-and-ethnicity-us-2010-2014.pdf. Accessed Oct 11, 2021.

Reference Type BACKGROUND

Henry KA, Sherman R, Farber S, Cockburn M, Goldberg DW, Stroup AM. The joint effects of census tract poverty and geographic access on late-stage breast cancer diagnosis in 10 US States. Health Place. 2013 May;21:110-21. doi: 10.1016/j.healthplace.2013.01.007. Epub 2013 Mar 1.

Reference Type BACKGROUND
PMID: 23454732 (View on PubMed)

DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017 Nov;67(6):439-448. doi: 10.3322/caac.21412. Epub 2017 Oct 3.

Reference Type BACKGROUND
PMID: 28972651 (View on PubMed)

Doescher MP, Jackson JE. Trends in cervical and breast cancer screening practices among women in rural and urban areas of the United States. J Public Health Manag Pract. 2009 May-Jun;15(3):200-9. doi: 10.1097/PHH.0b013e3181a117da.

Reference Type BACKGROUND
PMID: 19363399 (View on PubMed)

Roche LM, Niu X, Stroup AM, Henry KA. Disparities in Female Breast Cancer Stage at Diagnosis in New Jersey: A Spatial-Temporal Analysis. J Public Health Manag Pract. 2017 Sep/Oct;23(5):477-486. doi: 10.1097/PHH.0000000000000524.

Reference Type BACKGROUND
PMID: 28430705 (View on PubMed)

Williams F, Jeanetta S, O'Brien DJ, Fresen JL. Rural-urban difference in female breast cancer diagnosis in Missouri. Rural Remote Health. 2015 Jul-Sep;15(3):3063. Epub 2015 Jul 29.

Reference Type BACKGROUND
PMID: 26223824 (View on PubMed)

Vlahiotis A, Griffin B, Stavros AT, Margolis J. Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography. Clinicoecon Outcomes Res. 2018 Mar 26;10:157-167. doi: 10.2147/CEOR.S150260. eCollection 2018.

Reference Type BACKGROUND
PMID: 29618934 (View on PubMed)

Bleicher RJ. Timing and Delays in Breast Cancer Evaluation and Treatment. Ann Surg Oncol. 2018 Oct;25(10):2829-2838. doi: 10.1245/s10434-018-6615-2. Epub 2018 Jul 2.

Reference Type BACKGROUND
PMID: 29968031 (View on PubMed)

Bleicher RJ, Ruth K, Sigurdson ER, Ross E, Wong YN, Patel SA, Boraas M, Topham NS, Egleston BL. Preoperative delays in the US Medicare population with breast cancer. J Clin Oncol. 2012 Dec 20;30(36):4485-92. doi: 10.1200/JCO.2012.41.7972. Epub 2012 Nov 19.

Reference Type BACKGROUND
PMID: 23169513 (View on PubMed)

Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001 Jan 1;91(1):178-88. doi: 10.1002/1097-0142(20010101)91:13.0.co;2-s.

Reference Type BACKGROUND
PMID: 11148575 (View on PubMed)

Bradley CJ, Neumark D, Shickle LM, Farrell N. Differences in breast cancer diagnosis and treatment: experiences of insured and uninsured women in a safety-net setting. Inquiry. 2008 Fall;45(3):323-39. doi: 10.5034/inquiryjrnl_45.03.323.

Reference Type BACKGROUND
PMID: 19069013 (View on PubMed)

Drake BF, Abadin SS, Lyons S, Chang SH, Steward LT, Kraenzle S, Goodman MS. Mammograms on-the-go-predictors of repeat visits to mobile mammography vans in St Louis, Missouri, USA: a case-control study. BMJ Open. 2015 Mar 20;5(3):e006960. doi: 10.1136/bmjopen-2014-006960.

Reference Type BACKGROUND
PMID: 25795693 (View on PubMed)

Mizuguchi S, Barkley L, Rai S, Pan J, Roland L, Crawford S, Riley EC. Mobile Mammography, Race, and Insurance: Use Trends Over a Decade at a Comprehensive Urban Cancer Center. J Oncol Pract. 2015 Jan;11(1):e75-80. doi: 10.1200/JOP.2014.001477. Epub 2014 Nov 4.

Reference Type BACKGROUND
PMID: 25371543 (View on PubMed)

Schunemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nystrom L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Grawingholt A, Saz-Parkinson Z, European Commission Initiative on Breast Cancer Contributor G. Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann Intern Med. 2019

Reference Type BACKGROUND

Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, Egleston BL. Time to Surgery and Breast Cancer Survival in the United States. JAMA Oncol. 2016 Mar;2(3):330-9. doi: 10.1001/jamaoncol.2015.4508.

Reference Type BACKGROUND
PMID: 26659430 (View on PubMed)

Ashing-Giwa KT, Gonzalez P, Lim JW, Chung C, Paz B, Somlo G, Wakabayashi MT. Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors. Cancer. 2010 Jul 1;116(13):3195-204. doi: 10.1002/cncr.25060.

Reference Type BACKGROUND
PMID: 20564623 (View on PubMed)

Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006 Nov 13;166(20):2244-52. doi: 10.1001/archinte.166.20.2244.

Reference Type BACKGROUND
PMID: 17101943 (View on PubMed)

George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, Demissie K. Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Womens Health (Larchmt). 2015 Mar;24(3):209-17. doi: 10.1089/jwh.2014.4773. Epub 2015 Feb 4.

Reference Type BACKGROUND
PMID: 25650628 (View on PubMed)

Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB. Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care. 2005 Feb;43(2):141-8. doi: 10.1097/00005650-200502000-00007.

Reference Type BACKGROUND
PMID: 15655427 (View on PubMed)

Ryu EB, Chang JM, Seo M, Kim SA, Lim JH, Moon WK. Tumour volume doubling time of molecular breast cancer subtypes assessed by serial breast ultrasound. Eur Radiol. 2014 Sep;24(9):2227-35. doi: 10.1007/s00330-014-3256-0. Epub 2014 Jun 4.

Reference Type BACKGROUND
PMID: 24895040 (View on PubMed)

Neal RD, Tharmanathan P, France B, Din NU, Cotton S, Fallon-Ferguson J, Hamilton W, Hendry A, Hendry M, Lewis R, Macleod U, Mitchell ED, Pickett M, Rai T, Shaw K, Stuart N, Torring ML, Wilkinson C, Williams B, Williams N, Emery J. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer. 2015 Mar 31;112 Suppl 1(Suppl 1):S92-107. doi: 10.1038/bjc.2015.48.

Reference Type BACKGROUND
PMID: 25734382 (View on PubMed)

Polverini AC, Nelson RA, Marcinkowski E, Jones VC, Lai L, Mortimer JE, Taylor L, Vito C, Yim J, Kruper L. Time to Treatment: Measuring Quality Breast Cancer Care. Ann Surg Oncol. 2016 Oct;23(10):3392-402. doi: 10.1245/s10434-016-5486-7. Epub 2016 Aug 8.

Reference Type BACKGROUND
PMID: 27503492 (View on PubMed)

Kaufman CS, Shockney L, Rabinowitz B, Coleman C, Beard C, Landercasper J, Askew JB Jr, Wiggins D; Quality Initiative Committee. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010 Feb;17(2):377-85. doi: 10.1245/s10434-009-0729-5. Epub 2009 Oct 16.

Reference Type BACKGROUND
PMID: 19834768 (View on PubMed)

Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005 Sep;98(8):238-9.

Reference Type BACKGROUND
PMID: 16255115 (View on PubMed)

Brazda A, Estroff J, Euhus D, Leitch AM, Huth J, Andrews V, Moldrem A, Rao R. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010 Oct;17 Suppl 3:291-6. doi: 10.1245/s10434-010-1250-6. Epub 2010 Sep 19.

Reference Type BACKGROUND
PMID: 20853049 (View on PubMed)

Ramachandran A, Snyder FR, Katz ML, Darnell JS, Dudley DJ, Patierno SR, Sanders MR, Valverde PA, Simon MA, Warren-Mears V, Battaglia TA; Patient Navigation Research Program Investigators. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program. Cancer. 2015 Nov 15;121(22):4016-24. doi: 10.1002/cncr.29607. Epub 2015 Aug 19.

Reference Type BACKGROUND
PMID: 26385420 (View on PubMed)

Henderson LM, O'Meara ES, Haas JS, Lee CI, Kerlikowske K, Sprague BL, Alford-Teaster J, Onega T. The Role of Social Determinants of Health in Self-Reported Access to Health Care Among Women Undergoing Screening Mammography. J Womens Health (Larchmt). 2020 Nov;29(11):1437-1446. doi: 10.1089/jwh.2019.8267. Epub 2020 May 5.

Reference Type BACKGROUND
PMID: 32366199 (View on PubMed)

Fallahian F, Nelson H, Pories S. The Role of Social Determinants of Health on Cancer Screening. 2022; https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/june-2022-volume-107-number-6/the-role-of-social-determinants-of-health-on-cancer-screening/.

Reference Type BACKGROUND

Alegria M, Araneta MR, Rivers B. The National Advisory Council on Minority Health and Health Disparities Reflection. Am J Public Health. 2019 Jan;109(S1):S14-S15. doi: 10.2105/AJPH.2019.304961. No abstract available.

Reference Type BACKGROUND
PMID: 30699030 (View on PubMed)

Social Determinants of Health. Health topics 2022; https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1. Accessed September 30, 2022.

Reference Type BACKGROUND

Centers for Disease Control and Prevention. Addressing Social Determinants of Health: Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STD and TB. Atlanta, Georgia2009.

Reference Type BACKGROUND

Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Social Determinants of Health: Know What Affects Health. 2021; https://www.cdc.gov/socialdeterminants/.

Reference Type BACKGROUND

Maroko AR, Doan TM, Arno PS, Hubel M, Yi S, Viola D. Integrating Social Determinants of Health With Treatment and Prevention: A New Tool to Assess Local Area Deprivation. Prev Chronic Dis. 2016 Sep 15;13:E128. doi: 10.5888/pcd13.160221.

Reference Type BACKGROUND
PMID: 27634778 (View on PubMed)

Phillips RL, Liaw W, Crampton P, Exeter DJ, Bazemore A, Vickery KD, Petterson S, Carrozza M. How Other Countries Use Deprivation Indices-And Why The United States Desperately Needs One. Health Aff (Millwood). 2016 Nov 1;35(11):1991-1998. doi: 10.1377/hlthaff.2016.0709.

Reference Type BACKGROUND
PMID: 27834238 (View on PubMed)

DeMilto L, Nakashian M. Using social determinants of health data to improve health care and health: A learning report. Robert Wood Johnson Foundation. 2016;1:15

Reference Type BACKGROUND

Committee on Educating Health Professionals to Address the Social Determinants of Health; Board on Global Health; Institute of Medicine; National Academies of Sciences, Engineering, and Medicine. A Framework for Educating Health Professionals to Address the Social Determinants of Health. Washington (DC): National Academies Press (US); 2016 Oct 14. Available from http://www.ncbi.nlm.nih.gov/books/NBK395983/

Reference Type BACKGROUND
PMID: 27854400 (View on PubMed)

Garg A, Boynton-Jarrett R, Dworkin PH. Avoiding the Unintended Consequences of Screening for Social Determinants of Health. JAMA. 2016 Aug 23-30;316(8):813-4. doi: 10.1001/jama.2016.9282. No abstract available.

Reference Type BACKGROUND
PMID: 27367226 (View on PubMed)

Henderson V, Tossas-Milligan K, Martinez E, Williams B, Torres P, Mannan N, Green L, Thompson B, Winn R, Watson KS. Implementation of an integrated framework for a breast cancer screening and navigation program for women from underresourced communities. Cancer. 2020 May 15;126 Suppl 10:2481-2493. doi: 10.1002/cncr.32843.

Reference Type BACKGROUND
PMID: 32348565 (View on PubMed)

211 Get Help Give Help. 2022; https://211utah.org/. Accessed September 30, 2022.

Reference Type BACKGROUND

Wallace AS, Luther B, Guo JW, Wang CY, Sisler S, Wong B. Implementing a Social Determinants Screening and Referral Infrastructure During Routine Emergency Department Visits, Utah, 2017-2018. Prev Chronic Dis. 2020 Jun 18;17:E45. doi: 10.5888/pcd17.190339.

Reference Type BACKGROUND
PMID: 32553071 (View on PubMed)

Guo JW, Wallace AS, Luther BL, Wong B. Psychometric Evaluation of the Screener for Intensifying Community Referrals for Health. Eval Health Prof. 2022 Sep;45(3):270-276. doi: 10.1177/01632787211029360. Epub 2021 Jul 8.

Reference Type BACKGROUND
PMID: 34235988 (View on PubMed)

Wallace AS, Luther BL, Sisler SM, Wong B, Guo JW. Integrating social determinants of health screening and referral during routine emergency department care: evaluation of reach and implementation challenges. Implement Sci Commun. 2021 Oct 7;2(1):114. doi: 10.1186/s43058-021-00212-y.

Reference Type BACKGROUND
PMID: 34620248 (View on PubMed)

Sharareh N, Wallace AS, Brintz BJ, Wan N, Guo JW, Wong B. Associated factors with patient-reported unmet food needs among emergency department adult patients - A social need perspective. Prev Med Rep. 2022 Sep 7;29:101974. doi: 10.1016/j.pmedr.2022.101974. eCollection 2022 Oct.

Reference Type BACKGROUND
PMID: 36161133 (View on PubMed)

MQSA National Statistics. 2022; https://www.fda.gov/radiation-emitting-products/mqsa-insights/mqsa-national-statistics. Accessed May 20, 2022.

Reference Type BACKGROUND

Aday LA, Andersen R. A framework for the study of access to medical care. Health Serv Res. 1974 Fall;9(3):208-20.

Reference Type BACKGROUND
PMID: 4436074 (View on PubMed)

Andersen R, Bozzette S, Shapiro M, St Clair P, Morton S, Crystal S, Goldman D, Wenger N, Gifford A, Leibowitz A, Asch S, Berry S, Nakazono T, Heslin K, Cunningham W. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res. 2000 Jun;35(2):389-416.

Reference Type BACKGROUND
PMID: 10857469 (View on PubMed)

Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995 Mar;36(1):1-10.

Reference Type BACKGROUND
PMID: 7738325 (View on PubMed)

Andersen RM, Davidson PL. Improving access to care in America. Changing the US Health Care System. 2nd ed. San Fransisco: Josey-Bass; 2001.

Reference Type BACKGROUND

Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000 Feb;34(6):1273-302.

Reference Type BACKGROUND
PMID: 10654830 (View on PubMed)

Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res. 1998 Aug;33(3 Pt 1):571-96.

Reference Type BACKGROUND
PMID: 9685123 (View on PubMed)

Miller KA, Hillier D, Russ C, Luercio M, Winn AS. Applying Self-Determination Theory to Redesign an Inpatient Care Team. Acad Pediatr. 2019 Apr;19(3):351-353. doi: 10.1016/j.acap.2018.09.010. Epub 2018 Oct 9. No abstract available.

Reference Type BACKGROUND
PMID: 30312681 (View on PubMed)

Partelow S. A review of the social-ecological systems framework: applications, methods, modifications, and challenges. Ecology and Society. 2018;23(4)

Reference Type BACKGROUND

Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 Aug;27(8):987-993. doi: 10.1089/jwh.2017.6428. Epub 2018 Jan 15.

Reference Type BACKGROUND
PMID: 29334616 (View on PubMed)

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11.

Reference Type BACKGROUND
PMID: 29127715 (View on PubMed)

Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg. 2017 Jan;213(1):132-139.e2. doi: 10.1016/j.amjsurg.2016.03.014. Epub 2016 Jun 12.

Reference Type BACKGROUND
PMID: 27421187 (View on PubMed)

Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, Chrvala CA, Key CR, Poplack SP, Worden JK, Kessler LG. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997 Oct;169(4):1001-8. doi: 10.2214/ajr.169.4.9308451. No abstract available.

Reference Type BACKGROUND
PMID: 9308451 (View on PubMed)

Incidence Rate Report for Utah by County, Breast (Late Stage), 2014-2018, White Non-Hispanic, Female, All Ages. https://statecancerprofiles.cancer.gov/incidencerates/index.php?stateFIPS=49&areatype=county&cancer=055&race=07&sex=2&age=001&stage=211&year=0&type=incd&sortVariableName=rate&sortOrder=default&output=0#results. Accessed Oct 11, 2021.

Reference Type BACKGROUND

Onega T, Tosteson TD, Weiss J, Haas JS, Goodrich M, DiFlorio R, Brackett C, Clark C, Harris K, Tosteson ANA. Multi-level Influences on Breast Cancer Screening in Primary Care. J Gen Intern Med. 2018 Oct;33(10):1729-1737. doi: 10.1007/s11606-018-4560-1. Epub 2018 Aug 3.

Reference Type BACKGROUND
PMID: 30076569 (View on PubMed)

Beaber EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Schapira MM, McCarthy AM, Li CI, Herschorn SD, Lehman CD, Wernli KJ, Barlow WE. Multilevel Predictors of Continued Adherence to Breast Cancer Screening Among Women Ages 50-74 Years in a Screening Population. J Womens Health (Larchmt). 2019 Aug;28(8):1051-1059. doi: 10.1089/jwh.2018.6997. Epub 2018 Nov 27.

Reference Type BACKGROUND
PMID: 30481098 (View on PubMed)

Schapira MM, Barlow WE, Conant EF, Sprague BL, Tosteson ANA, Haas JS, Onega T, Beaber EF, Goodrich M, McCarthy AM, Herschorn SD, Skinner CS, Harrington TO, Geller B. Communication Practices of Mammography Facilities and Timely Follow-up of a Screening Mammogram with a BI-RADS 0 Assessment. Acad Radiol. 2018 Sep;25(9):1118-1127. doi: 10.1016/j.acra.2017.12.028. Epub 2018 Feb 9.

Reference Type BACKGROUND
PMID: 29433892 (View on PubMed)

Buist DSM, Gao H, Anderson ML, Onega T, Brandzel S, Rabelhofer MA, Bradford SC, Aiello Bowles EJ. Breast cancer screening outreach effectiveness: Mammogram-specific reminders vs. comprehensive preventive services birthday letters. Prev Med. 2017 Sep;102:49-58. doi: 10.1016/j.ypmed.2017.06.028. Epub 2017 Jun 24.

Reference Type BACKGROUND
PMID: 28655547 (View on PubMed)

Lee CI, Zhu W, Onega T, Henderson LM, Kerlikowske K, Sprague BL, Rauscher GH, O'Meara ES, Tosteson ANA, Haas JS, diFlorio-Alexander R, Kaplan C, Miglioretti DL. Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status. JAMA Netw Open. 2021 Feb 1;4(2):e2037546. doi: 10.1001/jamanetworkopen.2020.37546.

Reference Type BACKGROUND
PMID: 33606032 (View on PubMed)

Ozanne EM, Klemp JR, Esserman LJ. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr;12(2):103-13. doi: 10.1111/j.1075-122X.2006.00217.x.

Reference Type BACKGROUND
PMID: 16509834 (View on PubMed)

Euhus DM. Breast cancer prevention in the 21st century: defining the challenge. Breast J. 2006 Mar-Apr;12(2):97-8. doi: 10.1111/j.1075-122X.2006.00215.x. No abstract available.

Reference Type BACKGROUND
PMID: 16509832 (View on PubMed)

Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 2007 Mar-Apr;13(2):147-54. doi: 10.1111/j.1524-4741.2007.00395.x.

Reference Type BACKGROUND
PMID: 17319855 (View on PubMed)

Ozanne EM, Howe R, Omer Z, Esserman LJ. Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak. 2014 Jan 14;14:4. doi: 10.1186/1472-6947-14-4.

Reference Type BACKGROUND
PMID: 24422989 (View on PubMed)

Ozanne EM, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS. onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Res Treat. 2015 Nov;154(1):181-90. doi: 10.1007/s10549-015-3605-y.

Reference Type BACKGROUND
PMID: 26475704 (View on PubMed)

Ozanne EM, Soeteman DI, Frank ES, Clarke J, Hassett MJ, Stout NK, Punglia RS. Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ. Breast J. 2020 Jul;26(7):1498-1499. doi: 10.1111/tbj.13779. Epub 2020 Feb 8. No abstract available.

Reference Type BACKGROUND
PMID: 32034829 (View on PubMed)

Cancer Screening and Education Bus. Cancer Screening & Prevention https://healthcare.utah.edu/huntsmancancerinstitute/screening-prevention/mobile-screening.php. Accessed September 30, 2022.

Reference Type BACKGROUND

Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004 Sep;36(8):588-94.

Reference Type BACKGROUND
PMID: 15343421 (View on PubMed)

Chew LD, Griffin JM, Partin MR, Noorbaloochi S, Grill JP, Snyder A, Bradley KA, Nugent SM, Baines AD, Vanryn M. Validation of screening questions for limited health literacy in a large VA outpatient population. J Gen Intern Med. 2008 May;23(5):561-6. doi: 10.1007/s11606-008-0520-5. Epub 2008 Mar 12.

Reference Type BACKGROUND
PMID: 18335281 (View on PubMed)

Sarkar U, Schillinger D, Lopez A, Sudore R. Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. J Gen Intern Med. 2011 Mar;26(3):265-71. doi: 10.1007/s11606-010-1552-1. Epub 2010 Nov 6.

Reference Type BACKGROUND
PMID: 21057882 (View on PubMed)

Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR, Duffy SW, Howell A, Cuzick J. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res. 2014 Oct 8;16(5):451. doi: 10.1186/s13058-014-0451-5.

Reference Type BACKGROUND
PMID: 25292294 (View on PubMed)

Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994 Nov;47(11):1245-51. doi: 10.1016/0895-4356(94)90129-5.

Reference Type BACKGROUND
PMID: 7722560 (View on PubMed)

Hailu D, Asnake. Guidelines for Using Rural-Urban Classification Systems for Community Health Assessment. In: Health WSDo, ed: Washington State Department of Health; 2016:1-26.

Reference Type BACKGROUND

Knighton AJ, Savitz L, Belnap T, Stephenson B, VanDerslice J. Introduction of an Area Deprivation Index Measuring Patient Socioeconomic Status in an Integrated Health System: Implications for Population Health. EGEMS (Wash DC). 2016 Aug 11;4(3):1238. doi: 10.13063/2327-9214.1238. eCollection 2016.

Reference Type BACKGROUND
PMID: 27683670 (View on PubMed)

Onega T, Haas JS, Bitton A, Brackett C, Weiss J, Goodrich M, Harris K, Pyle S, Tosteson AN. Alignment of breast cancer screening guidelines, accountability metrics, and practice patterns. Am J Manag Care. 2017 Jan;23(1):35-40.

Reference Type BACKGROUND
PMID: 28141929 (View on PubMed)

Schiffelbein JE, Carluzzo KL, Hasson RM, Alford-Teaster JA, Imset I, Onega T. Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720930544. doi: 10.1177/2150132720930544.

Reference Type BACKGROUND
PMID: 32506999 (View on PubMed)

Raffin E, Onega T, Bynum J, Austin A, Carmichael D, Bronner K, Goodney P, Hyams ES. Are there regional tendencies toward controversial screening practices? A study of prostate and breast cancer screening in a Medicare population. Cancer Epidemiol. 2017 Oct;50(Pt A):68-75. doi: 10.1016/j.canep.2017.07.015. Epub 2017 Aug 17.

Reference Type BACKGROUND
PMID: 28822325 (View on PubMed)

Haas J, Schapira M, Sprague B, Tosteson A, Klabunde C, Chen J, Bitton A, Beaber E, Onega T, Kim J, MacLean C. Changes in Primary Care Practice Following New USPSTF Breast and Cervical Cancer Screening Guidelines. AcademyHealth 2015 Annual Research Meeting; June 15, 2015.

Reference Type BACKGROUND

National Cancer Institute Division of Cancer Control & Population Sciences. Population-based Research to Optimize the Screening Process (PROSPR). 2021; https://healthcaredelivery.cancer.gov/prospr/prospr1/.

Reference Type BACKGROUND

Cozzi A, Schiaffino S, Giorgi Rossi P, Sardanelli F. Breast cancer screening: in the era of personalized medicine, age is just a number. Quant Imaging Med Surg. 2020 Dec;10(12):2401-2407. doi: 10.21037/qims-2020-26. No abstract available.

Reference Type BACKGROUND
PMID: 33269240 (View on PubMed)

Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL; PROSPR consortium. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr;31(4):372-9. doi: 10.1007/s11606-015-3552-7.

Reference Type BACKGROUND
PMID: 26658934 (View on PubMed)

Baum JK, Hanna LG, Acharyya S, Mahoney MC, Conant EF, Bassett LW, Pisano ED. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial. Radiology. 2011 Jul;260(1):61-7. doi: 10.1148/radiol.11101285. Epub 2011 Apr 18.

Reference Type BACKGROUND
PMID: 21502382 (View on PubMed)

Breast Imaging Reporting & Data System (BI-RADS (R)). 2013; https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads. Accessed July 25, 2022.

Reference Type BACKGROUND

Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Heerdt AS, Helvie M, Huff JG, Khakpour N, Khan SA, Krontiras H, Lyman G, Rafferty E, Shaw S, Smith ML, Tsangaris TN, Williams C, Yankeelov T; National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96. doi: 10.6004/jnccn.2009.0070. No abstract available.

Reference Type BACKGROUND
PMID: 19930975 (View on PubMed)

Guest G, MacQueen KM, Namey EE. Applied Thematic Analysis. SAGE Publications, Inc.; 2012.

Reference Type BACKGROUND

Glaser BG, Strauss AL. Discovery of Grounded Theory: Strategies for Qualitative Research. Routledge; 2017.

Reference Type BACKGROUND

Krippendorff K. Quantitative guidelines for communicable disease control programs. Biometrics. 1978 Mar;34(1):142. No abstract available.

Reference Type BACKGROUND
PMID: 630036 (View on PubMed)

Morse JM. The Significance of Saturation. Qualitative Health Research. 1995;5(2):147-149

Reference Type BACKGROUND

Guest G, Bunce A, Johnson L. How Many Interviews Are Enough?:An Experiment with Data Saturation and Variability. Field Methods. 2006;18(1):59-82

Reference Type BACKGROUND

Center for HOPE. 2022; https://healthcare.utah.edu/huntsmancancerinstitute/about-us/center-for-hope.php. Accessed September 30, 2022.

Reference Type BACKGROUND

Center for HOPE. Huntsman Cancer Institute Research 2022; https://uofuhealth.utah.edu/huntsman/labs/center-for-hope. Accessed September 30, 2022.

Reference Type BACKGROUND

Beck K, Mitchell M, Wallace AS, Freer PE, Wong B, Kepka D, Watt MH, McNall S, Kolomaya A, Ariotti A, Mulford M, Onega T, Ozanne EM. Community navigation intervention for social needs in patients with abnormal mammography: a randomized controlled trial study protocol. BMC Public Health. 2025 Aug 26;25(1):2926. doi: 10.1186/s12889-025-24372-x.

Reference Type DERIVED
PMID: 40859259 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01CA282409-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

HCI166685

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Partnership for Healthy Seniors
NCT00379743 COMPLETED NA